| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $80.00M | $2.81M | $6.34M | $19.16M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $84.77M | $101.90M | $113.47M | $118.90M | $100.22M |
| R&D | $56.10M | $63.39M | $71.80M | $76.78M | $69.70M |
| SG&A | $28.67M | $36.45M | $41.67M | $41.69M | $30.52M |
| Operating Income | -$84.77M | -$21.90M | -$110.66M | -$112.56M | -$81.05M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$74.88M | -$9.72M | -$97.33M | -$109.87M | -$80.85M |
| EPS (basic) | -1.1800 | -0.1600 | -1.5900 | -2.4400 | -2.2900 |
| EPS (diluted) | -1.1800 | -0.1600 | -1.5900 | -2.4400 | -2.2900 |
| Shares (diluted) | $63.35K | $61.98K | $61.31K | $44.99K | $35.36K |